James Pingpank, MD

General Surgeon

Conditions Treated

Lung Cancer Ovarian Cancer Peritoneal Mesothelioma Pleural Effusions Testicular Mesothelioma

Bio & Insurance Information

Dr. Pingpank having graduated from the George Washington University School of Medicine in 1992, is currently practicing as an associate professor at the University of Pennsylvania Medical Center, Mesothelioma Specialty Care Center. Dr. James Pingpank completed two residencies, at the at the University of Connecticut Health Sciences Center in Farmington and University of Pennsylvania Medical Center. His fellowship was completed at the Fox Chase Cancer Center. Trained as a surgical oncologist, Dr. Pingpank’s specialty is in the treatment of peritoneal mesothelioma. With over 40 works published and peer-reviewed, Dr. Pingpank is attempting to give hope to those suffering from this very serious type of cancer, mesothelioma.


Education & Training

George Washington University School of Medicine - 1992

Medical School

University of Pennsylvania Medical Center and Connecticut at the University of Connecticut Health Sciences Center

Residency

Fox Chase Cancer Center

Fellowship

Board Certifications

American Board of Surgery

Hospitals & Clinics

Hillman Cancer Center - UPMC

Languages: English/Spanish

(412) 623-5864

5115 Centre Ave

Pittsburgh, Pennsylvania 15232

Read More

Magee Womens Hospital of UPMC Pittsburgh

Languages: English/Spanish

(412) 641-1000

300 Halket St

Pittsburgh, Pennsylvania 15213

Read More

UPMC Mercy

Languages: English/Spanish

(412) 232-8111

1400 Locust St

Pittsburgh, Pennsylvania 15219

Read More

UPMC Shadyside

Languages: English/Spanish

(412) 623-2121

5230 Centre Ave

Pittsburgh, Pennsylvania 15232

Read More

Publications

Dr. James Pingpank has contributed to 3 publications.

Prognostic significance of morphological growth patterns and mitotic index of epithelioid malignant peritoneal mesothelioma.

Krasinskas AM1, Borczuk AC2, Hartman DJ1, Chabot JA3, Taub RN4, Mogal A1, Pingpank J5, Bartlett D5, Dacic S1.

See more >>

Outcomes of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemoperfusion in Patients with High-Grade, High-Volume Disseminated Mucinous Appendiceal Neoplasms.

Polanco PM1, Ding Y2, Knox JM3, Ramalingam L3, Jones H3, Hogg ME3, Zureikat AH3, Holtzman MP3, Pingpank J3, Ahrendt S3, Zeh HJ3, Bartlett DL4, Choudry HA5.

See more >>

Effect of a concomitant urologic procedure on outcomes following cytoreductive surgery with hyperthermic intraperitoneal chemotherapy.

Lyon TD1, Turner Ii RM1, Nikonow TN1, Wang L2, Uy J1, Ramalingam L3, Holtzman MP3, Pingpank JF3, Bartlett DL3, Davies BJ1.

See more >>

Memberships

American College of Surgeons

February 24, 2014

by Mark Fassio

Wait Time

Staff

Helpfulness

Knowledge

“I live in KY and was diagnosed with stage IV signet cell appendix cancer, the worst of worst. I grew up in western PA and I had no doubt that UPMC is the place I need to go to get treated. Dr. Pingpank is professional and very accurate in diagnosis. He is part of that category of doctors who take time and listen to the patient’s questions. This great man saved my life!”